GASTRIC ADENOCARCINOMA
Clinical trials for GASTRIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTRIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Stomach cancer chemo study stopped early – too few volunteers
Disease control TerminatedThis study aimed to see if giving all chemotherapy before surgery (FLOT-TNT) was better than splitting it before and after surgery (FLOT-POP) for stomach or GEJ cancer. Only 3 people took part, and the study was stopped early. Because of this, no reliable conclusions can be drawn…
Matched conditions: GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 11:34 UTC
-
New chemo cocktail targets stomach cancer in the belly
Disease control TerminatedThis study tested a new way to give chemotherapy for stomach cancer that has spread throughout the belly (peritoneal carcinomatosis). Participants received one chemo drug through a port in the belly and through a vein, plus another chemo drug by mouth. The goal was to see if this…
Matched conditions: GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 11:34 UTC
-
Cancer drug combo trial halted early: what we learned
Disease control TerminatedThis study tested a combination of two drugs, niraparib and dostarlimab, in adults with advanced solid tumors that either had DNA repair problems or were sensitive to platinum chemotherapy. The goal was to see how many patients' tumors shrank or disappeared. The trial was stopped…
Matched conditions: GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated May 26, 2026 11:33 UTC
-
Experimental cancer pill trial halted early
Disease control TerminatedThis early-stage study tested an experimental pill called PRT7732 in people with advanced solid tumors that have a specific genetic mutation (SMARCA4). The main goals were to check safety, find the right dose, and see if the drug shrinks tumors. The study was terminated early, an…
Matched conditions: GASTRIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated May 26, 2026 11:29 UTC
-
Surgery-Chemo combo for stomach cancer: hope or halt?
Disease control TerminatedThis study looked at whether removing the main stomach tumor and treating the single spot where cancer had spread, along with chemotherapy, helps people with stage IV stomach cancer live longer. It was designed for patients whose cancer had not worsened after initial chemo. The t…
Matched conditions: GASTRIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Stomach cancer drug combo trial halted early – what we know
Disease control TerminatedThis study tested a new drug (DKN-01) combined with an immunotherapy (tislelizumab) and chemotherapy for people with advanced stomach or gastroesophageal junction cancer that could not be removed by surgery. The trial aimed to see if the combination was safe and could slow cancer…
Matched conditions: GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Leap Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC